Overview

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Status:
Active, not recruiting
Trial end date:
2026-04-27
Target enrollment:
Participant gender:
Summary
A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Treatments:
Docetaxel